Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlushCare vs Zeuss

PlushCare
Graded #64

Higher grade

vs+5.599999999999994
Zeuss
Graded #141

Lower grade

The verdict

PlushCare takes it — 74.5/100 to 68.9/100.

PlushCare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established virtual primary-care telehealth platform (subsidiary of Transcarent, Inc., a Delaware corporation, alongside Accolade, 2nd.MD, and 98point6 by Transcarent).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueZeuss +10
74
84
Dose & formulationPlushCare +13
77
64
Clinical oversightPlushCare +10
82
72
Labs & monitoringPlushCare +25
77
52
FulfillmentPlushCare +11
78
67
Contract termsZeuss +20
41
61
PlushCare · left barZeuss · right bar

The numbers

MetricPlushCareZeuss
WeighScore74.5/10068.9/100
GradeCC
Scorecard rank#64#141
Semaglutide$149/mo (starting dose, compounded)$125/mo (compounded)
Tirzepatide$399/mo (starting dose, compounded)$175/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
PlushCare

Graded #64 · C

Strengths

  • Available in all 50 states
  • Appointments with US board-certified physicians, not nurse practitioners only
  • Virtual primary care — the same doctor can manage GLP-1s alongside other health needs
  • Owned by Transcarent, a venture-backed health platform with a named corporate parent

Where it loses points

  • Facing a California class action alleging deceptive subscription enrollment and unauthorized charges after cancellation
  • GLP-1 prescribing is up to the clinician at the visit — not guaranteed at signup
  • BBB complaints center on the membership cancellation process
Zeuss

Graded #141 · C

Strengths

  • One-time-purchase model with no subscription — genuinely rare among DTC GLP-1 providers
  • Publishes the FDA compounded-medication disclaimer
  • Names both 503A and 503B compounding pathways — uncommon transparency
  • Bundled pricing covers provider review, meds, and cold-chain shipping with no hidden fees
  • Full refund if a physician can't prescribe

Where it loses points

  • 503A pharmacy partner not named (only generic '503A and 503B state-licensed' framing)
  • LegitScript certification not mentioned
  • No named medical director or physician leadership
  • Full states-served list not disclosed
  • Corporate legal entity not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard